Thomas J.  Spoerel net worth and biography

Thomas Spoerel Biography and Net Worth

Thomas J. Spoerel is Chief Accounting Officer, Principal Accounting Officer, Vice President, Controller of the Company. Mr. Spoerel joined BD in September 2015 as Vice President Finance and Deputy Controller, and became Vice President Finance and Controller in December 2018. Prior to joining BD, Mr. Spoerel served as Vice President Finance and Corporate Controller of Catalent, Inc.

What is Thomas J. Spoerel's net worth?

The estimated net worth of Thomas J. Spoerel is at least $455,942.24 as of June 10th, 2024. Mr. Spoerel owns 1,976 shares of Becton, Dickinson and Company stock worth more than $455,942 as of July 22nd. This net worth approximation does not reflect any other assets that Mr. Spoerel may own. Learn More about Thomas J. Spoerel's net worth.

How old is Thomas J. Spoerel?

Mr. Spoerel is currently 45 years old. There are 7 older executives and no younger executives at Becton, Dickinson and Company. The oldest executive at Becton, Dickinson and Company is Mr. David B. Hickey, Executive VP & President of Life Sciences Segment, who is 60 years old. Learn More on Thomas J. Spoerel's age.

How do I contact Thomas J. Spoerel?

The corporate mailing address for Mr. Spoerel and other Becton, Dickinson and Company executives is 1 BECTON DRIVE, FRANKLIN LAKES NJ, 07417. Becton, Dickinson and Company can also be reached via phone at (201) 847-6800 and via email at [email protected]. Learn More on Thomas J. Spoerel's contact information.

Has Thomas J. Spoerel been buying or selling shares of Becton, Dickinson and Company?

Thomas J. Spoerel has not been actively trading shares of Becton, Dickinson and Company during the last quarter. Learn More on Thomas J. Spoerel's trading history.

Who are Becton, Dickinson and Company's active insiders?

Becton, Dickinson and Company's insider roster includes Simon Campion (EVP), Alexandre Conroy (EVP), Christopher DelOrefice (Exec. VP & CFO ), Claire Fraser (Director), John Gallagher (VP), Michael Garrison (EVP), Roland Goette (EVP), David Hickey (EVP), Patrick Kaltenbach (EVP), Samrat Khichi (EVP), Betty Larson (EVP), James Lim (EVP), Thomas Polen, Jr. (Insider), Rebecca Rimel (Director), and Thomas Spoerel (VP). Learn More on Becton, Dickinson and Company's active insiders.

Are insiders buying or selling shares of Becton, Dickinson and Company?

During the last year, insiders at the medical instruments supplier sold shares 10 times. They sold a total of 16,634 shares worth more than $4,166,149.15. The most recent insider tranaction occured on June, 10th when SVP Thomas J Spoerel sold 300 shares worth more than $71,793.00. Insiders at Becton, Dickinson and Company own 0.3% of the company. Learn More about insider trades at Becton, Dickinson and Company.

Information on this page was last updated on 6/10/2024.

Thomas J. Spoerel Insider Trading History at Becton, Dickinson and Company

See Full Table

Thomas J. Spoerel Buying and Selling Activity at Becton, Dickinson and Company

This chart shows Thomas J. Spoerel's buying and selling at Becton, Dickinson and Company by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Becton, Dickinson and Company Company Overview

Becton, Dickinson and Company logo
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
Read More

Today's Range

Now: $230.74
Low: $229.45
High: $235.05

50 Day Range

MA: $232.42
Low: $221.47
High: $240.63

2 Week Range

Now: $230.74
Low: $218.75
High: $287.32

Volume

1,075,000 shs

Average Volume

1,431,099 shs

Market Capitalization

$66.69 billion

P/E Ratio

50.82

Dividend Yield

1.64%

Beta

0.42